Skip to main content

Advertisement

SpringerLink
Log in

Combined Modality Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus Statement

  • CONSENSUS REPORT: RESECTABLE AND BORDERLINE RESECTABLE PANCREAS CANCER
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kalser MH, Ellenberg SS. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg. 1985;120:899–903.

    PubMed  CAS  Google Scholar 

  2. Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med. 2004;350:1200–10.

    Article  PubMed  CAS  Google Scholar 

  3. Klinkenbijl JH, Jeekel J, Sahmoud T, van Pel R, Couvreur ML, Veenhof CH, et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg. 1999;230:776–82;discussion 82–4.

    Article  PubMed  CAS  Google Scholar 

  4. Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA. 2007;297:267–77.

    Article  PubMed  CAS  Google Scholar 

  5. Regine WF, Winter KA, Abrams RA, Safran H, Hoffman JP, Konski A, et al. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial. JAMA. 2008;299:1019–26.

    Article  PubMed  CAS  Google Scholar 

  6. Griffin JF, Smalley SR, Jewell W, Paradelo JC, Reymond RD, Hassanein RE, et al. Patterns of failure after curative resection of pancreatic adenocarcinomas. Cancer. 1990;66:56–61.

    Article  PubMed  CAS  Google Scholar 

  7. Tepper J, Nardi G, Suit H. Carcinoma of the pancreas: Review of MGH experience from 1963–1973—Analysis of surgical failure and its implications for radiation therapy. Cancer. 1976;37:1519–24.

    Article  PubMed  CAS  Google Scholar 

  8. Evans DB, Rich TA, Byrd DR, Cleary KR, Connelly JH, Levin B, et al. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg. 1992;127:1335–9.

    PubMed  CAS  Google Scholar 

  9. Pisters PW, Abbruzzese JL, Janjan NA, Cleary KR, Charnsangavej C, Goswitz MS, et al. Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma. J Clin Oncol. 1998;16:3843–50.

    PubMed  CAS  Google Scholar 

  10. Evans DB, Varadhachary GR, Crane CH, Sun CC, Lee JE, Pisters PW, et al. Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. J Clin Oncol. 2008;26:3496–502.

    Article  PubMed  CAS  Google Scholar 

  11. Varadhachary GR, Wolff RA, Crane CH, Sun CC, Lee JE, Pisters PW, et al. Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. J Clin Oncol. 2008; 26:3487–95.

    Article  PubMed  CAS  Google Scholar 

  12. Smeenk HG, van Eijck CH, Hop WC, Erdmann J, Tran KC, Debois M, et al. Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: long-term results of EORTC trial 40891. Ann Surg. 2007;246:734–40.

    Article  PubMed  Google Scholar 

  13. Neoptolemos JP, Dunn JA, Stocken DD, Almond J, Link K, Beger H, et al. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet. 2001;358:1576–85.

    Article  PubMed  CAS  Google Scholar 

  14. Abrams RA, Grochow LB. Adjuvant therapy with chemotherapy and radiation therapy in the management of carcinoma of the pancreatic head. Surg Clin North Am. 1995;75:925–38.

    PubMed  CAS  Google Scholar 

  15. Hsu CC, Herman JM, Corsini MM, et al. Benefit of adjuvant chemoradiation therapy for pancreatic adenocarcinoma: The Johns Hopkins Hospital-Mayo clinic collaborative study of 1,045 patients. J Clin Oncol. 2008;26:3503–10.

    Article  PubMed  Google Scholar 

  16. Corsini MM, Miller RC, Haddock MG, Donohue JH, Farnell MB, Nagorney DM, et al. Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma. The Mayo Clinic Experience (1975–2005). J Clin Oncol. 2008;26:3511–6.

    Google Scholar 

  17. Picozzi VJ, Abrams RA, Traverso LW, O’Reilly EM, Greeno E, Martin R, et al. ACOSOG Z05031: Initial report of a multicenter, phase II trial of novel chemoradiation protocol using cisplatin, 5-FU, and alpha-interferon as adjuvant therapy for resected pancreas cancer. J Clin Oncol. 2008 Annual Meeting Proceedings (May Supplement), 125.

  18. Bakkevold KE, Arnesjo B, Dahl O, Kambestad B. Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater–results of a controlled, prospective, randomised multicentre study. Eur J Cancer. 1993;29A:698–703.

    Article  PubMed  CAS  Google Scholar 

  19. Berger A, Winter KA, Hoffman JP, et al. Post-resection CA 19-9 predicts overall survival (OS) in patients treated with adjuvant chemoradiation: A secondary endpoint of RTOG 9704. J Clin Oncol. 2007 Annual Meeting Proceedings Part 1, Vol 25, No. 18S (June Supplement), 207:4522.

  20. Abrams RA, Winter KA, Regine WF, Safran H, Hoffman JP, Konski AA, et al. RTOG 97-04—Radiotherapy Quality Assurance (QA) Review and Survival. Proceedings of ASTRO, Int J Radiat Oncol Biol Phys. 2006;66:S22.

    Google Scholar 

  21. Van Laethem J, Van Cutsem E, Hammel P, Mornex F, Azria D, Van Tienhoven G, et al. Adjuvant chemotherapy alone versus chemoradiation after curative resection for pancreatic cancer: feasibility results of a randomized EORTC/FFCD/GERCOR phase I/II study (40013/22012/0304)-abstract 4514. J Clin Oncol 2008;26:216s.

    Google Scholar 

  22. National Comprehensive Cancer Network (NCCN) NCCN Updates Pancreatic Adenocarcinoma Guidelines, 2007. http://www.nccn.org/about/news/newsinfo.asp?NewsID=124.

  23. Lu DS, Reber HA, Krasny RM, Kadell BM, Sayre J. Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT. AJR Am J Roentgenol. 1997;168:1439–43.

    PubMed  CAS  Google Scholar 

  24. Capussotti L, Massucco P, Ribero D, Vigano L, Muratore A, Calgaro M. Extended lymphadenectomy and vein resection for pancreatic head cancer: outcomes and implications for therapy. Arch Surg. 2003;138:1316–22.

    Article  PubMed  Google Scholar 

  25. van Geenen RC, ten Kate FJ, de Wit LT, van Gulik TM, Obertop H, Gouma DJ. Segmental resection and wedge excision of the portal or superior mesenteric vein during pancreatoduodenectomy. Surgery. 2001;129:158–63.

    Article  PubMed  Google Scholar 

  26. Varadhachary GR, Tamm EP, Abbruzzese JL, Xiong HQ, Crane CH, Wang H, et al. Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol. 2006;13:1035–46.

    Article  PubMed  Google Scholar 

  27. Katz MHG, Pisters PW, Evans DB, et al. Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am College Surgeons. 2008;206:833–48.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Rush University Medical Center, Chicago, IL, USA

    Ross A. Abrams MD

  2. Division of Surgical Oncology, University of California at San Diego, San Diego, CA, USA

    Andrew M. Lowy MD

  3. Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, USA

    Eileen M. O’Reilly MD

  4. Department of Gastrointestinal Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA

    Robert A. Wolff MD

  5. Pancreaticobiliary Cancer, - Digestive Diseases Institute, Virginia Mason Medical Center, Seattle, WA, USA

    Vincent J. Picozzi MD, MMM

  6. Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA

    Peter W. T. Pisters MD

Authors
  1. Ross A. Abrams MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrew M. Lowy MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eileen M. O’Reilly MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Robert A. Wolff MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Vincent J. Picozzi MD, MMM
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Peter W. T. Pisters MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter W. T. Pisters MD.

Additional information

Proceedings of the Consensus Conference sponsored by the American Hepato-Pancreato-Biliary Association and Co-Sponsored by The Society for Surgery of the Alimentary Tract, The Society of Surgical Oncology, The Gastrointestinal Symposium Steering Committee, and The University of Texas M. D. Anderson Cancer Center held in Orlando, FL, January 24, 2008

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abrams, R.A., Lowy, A.M., O’Reilly, E.M. et al. Combined Modality Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus Statement. Ann Surg Oncol 16, 1751–1756 (2009). https://doi.org/10.1245/s10434-009-0413-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-009-0413-9

Keywords

Search

Navigation